Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
07/1996
07/10/1996EP0720855A2 Composition for the treatment of hypertension comprising non halide salts of potassium
07/10/1996EP0457888B1 Octapeptide analogs of somatostatin having threonine at the sixth position
07/03/1996EP0719776A1 8-Oxo-5,8-dihydro-6H-dibenzo(a,g) quinolizine-13-propanoic acid derivatives, their preparation and therapeutic use
07/03/1996EP0719277A1 Androstenones
07/03/1996EP0719146A1 Novel method of progesterone delivery and affect thereof
07/03/1996EP0719143A1 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
07/03/1996EP0719140A1 Use of thiazolidinediones to prevent or delay onset of niddm
07/02/1996US5532925 Current-to-pressure transducer with selectable, adjustable input filter
07/02/1996US5532400 2,6-di-alkyl-4-silyl-phenols as antiatheroscelerotic agents
06/1996
06/30/1996CA2166233A1 8-oxo-5,8-dihydro-6h-dibenzo¬a,g|quinolizine-13-propanoic acid derivatives, their preparation and their therapeutic application
06/27/1996WO1996019458A2 Steroid receptor modulator compounds and methods
06/27/1996WO1996019455A1 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists
06/27/1996WO1996019203A1 Transdermal system for the simultaneous delivery of a number of active principles
06/27/1996CA2208374A1 Transdermal system for the simultaneous delivery of a number of active principles
06/27/1996CA2208347A1 Steroid receptor modulator compounds and methods
06/27/1996CA2208011A1 Aryl-and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists
06/26/1996EP0718286A1 3-Alkoxybenzylpiperidine derivatives as melatonergic agents
06/26/1996CN1125436A Vitamin D amide derivatives
06/25/1996US5530012 3-alkoxybenzylpiperidine derivatives as melatonergic agents
06/25/1996US5529993 Urogenital disorders; contraceptives
06/23/1996CA2165603A1 3-alkoxybenzylpiperidine derivatives as melatonergic agents
06/20/1996WO1996018651A1 Human somatostatin-like receptor
06/19/1996CN1124978A Cell matrix stimulated cell attachment and hemidesmosome assembly
06/18/1996US5527807 Treating alopecia, acne, prostate disorders
06/12/1996EP0715518A1 Agent for transdermal application containing gestoden esters
06/11/1996US5525613 Covalently coupled benzoylecgonine ecgonine and ecgonidine
06/11/1996US5525594 Administering a plant extract oenotheine b to inhibit 5 alpha-reductase
06/06/1996WO1996016542A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
06/04/1996US5523298 Used to induce labor, abortion, menstruation, and againsts hormonal irregularities
05/1996
05/30/1996WO1996015804A1 Acylated insulin analogs
05/30/1996CA2205060A1 Acylated insulin analogs
05/29/1996EP0713699A2 Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
05/29/1996EP0415924B1 Regulation of cell proliferation and differentiation using peptides
05/23/1996WO1996015148A2 Low molecular weight peptidomimetic growth hormone secretagogues
05/23/1996WO1996009831A3 Compositions containing at least one glucocorticoid in combination with a pulmonary surfactant for the treatment of irds and ards
05/23/1996WO1996009826A3 Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
05/23/1996CA2203375A1 Low molecular weight peptidomimetic growth hormone secretagogues
05/22/1996EP0712861A2 Acylated insulin analogs
05/22/1996EP0712412A1 15,15-dialkyl-substituted derivatives of estradiol
05/22/1996EP0712303A1 Skin patches and methods for providing testosterone
05/21/1996US5519116 Peptides representing permutations of the mastoparan sequence
05/21/1996US5519027 D-homo-(16-ene)-11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
05/17/1996WO1996014082A1 Methods and kits using macrophage stimulating protein
05/15/1996EP0711287A1 Benzo-fused lactams promote release of growth hormone
05/15/1996CN1122248A Insulin analog formulations
05/15/1996CN1122226A Tablet, capsule, or granule comprising desogestrel
05/14/1996US5516887 Luteinizing hormone releasing hormone antagonist peptides
05/14/1996US5516769 Administering an antiprogestin to prevent ovulation or interfere with the menstrual cycle of a mammal
05/09/1996WO1996013585A1 A novel family of protease inhibitors, and other biologic active substances
05/09/1996WO1996013265A1 4-heterocyclic piperidines promote release of growth hormone
05/09/1996CA2203827A1 Novel family of protease inhibitors, and other biologic active substances
05/09/1996CA2202784A1 4-heterocyclic piperidines promote release of growth hormone
05/08/1996EP0710278A1 Cell matrix stimulated cell attachment and hemidesmosome assembly
05/08/1996EP0710230A1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists
05/08/1996EP0517778B1 Vasoactive vasotocin derivatives
05/08/1996CN1121821A Health Chinese medicine Massa Medicata fermentata oral liquid and its preparing method
05/07/1996US5514673 Pharmaceutical composition containing lipophilic drugs
05/01/1996EP0708656A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
05/01/1996CN1121709A Oxytocin antagonist
04/1996
04/30/1996US5512583 Methods of decreasing serum calcium levels
04/30/1996CA1338302C Therapeutic octapeptide somatostatin analogs
04/30/1996CA1338301C Therapeutic octapeptide somatostatin analogs
04/25/1996WO1996012034A1 A microbiological process for the preparation of 17beta-carboxy substituted 3-oxo-4-azasteroids and the use of such products as inhibitors of the enzyme 5alpha-reductase
04/24/1996EP0707596A1 Conjugation-stabilized polypeptide compositions
04/23/1996US5510498 Benzothiophene compounds, intermediates, compositions, and methods
04/23/1996US5510464 Administration of low dose hemoglobin to increase perfusion
04/23/1996US5510358 Osteoporosis
04/23/1996US5510357 Benzothiophene compounds as anti-estrogenic agents
04/23/1996US5510350 Useful in treatment or prophylaxis of depression and other central nervous system disorders
04/23/1996US5510263 Growth of pancreatic islet-like cell clusters
04/17/1996EP0706994A1 Melatonergic agents
04/17/1996CN1120843A 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity
04/17/1996CN1120549A Calcitonin analogue and use thereof
04/17/1996CN1120458A Physiologically active peptide compositions
04/17/1996CN1120457A Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
04/17/1996CN1031574C Process for preparation of 4-amino-delta-4, 6-steroid(s) compounds
04/11/1996WO1996010634A1 Inhibitor of stem cell proliferation and uses thereof
04/10/1996CN1120311A Pharmaceutical composition containing lipophilic drugs
04/09/1996US5506339 Octapeptide analogs of somatostatin having threonine at the sixth position
04/09/1996US5506107 Selecting ligand agonists and antagonists
04/04/1996WO1996010088A1 DEFFECTIVE RECOMBINANT ADENOVIRUSES WITH INACTIVATED IVa2 GENE
04/04/1996WO1996010040A1 Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
04/04/1996WO1996009831A2 Compositions containing at least one glucocorticoid in combination with a pulmonary surfactant for the treatment of irds and ards
04/04/1996WO1996009826A2 Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
04/04/1996CA2201122A1 Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
04/04/1996CA2200858A1 Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
04/04/1996CA2197904A1 Deffective recombinant adenoviruses with inactivated iva2 gene
04/03/1996EP0704448A1 Heterocyclic substituted imidazolidines, process and intermediates for their preparation, their use as medicaments and pharmaceutical compositions containing them
04/02/1996US5504188 Crystallization of lys(b28)pro(b29)-human insulin zinc salt at a ph of about 5.5 to 6.5 from a solution also containing acetic acid, citric acid, glycine or phenolic compound
03/1996
03/30/1996CA2159425A1 New heterocycle substituted imidazolidines; process and intermediates for preparing them and their use as drugs; pharmaceutical compositions containing the same
03/28/1996WO1996009046A1 5α-REDUCTASE INHIBITORS
03/28/1996WO1996009045A1 Antiestrogenic benzothiophenyl compounds
03/27/1996EP0703221A1 5 alpha-reductase Inhibitors
03/21/1996DE19534744A1 Neues pharmazeutisches Produkt New pharmaceutical product
03/20/1996EP0556332B1 Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents
03/20/1996CN1118781A Heterocyclic compound with activity against diabetes and preparation and application of same
03/14/1996WO1996007418A1 Phosphonates and parathyroid hormone for osteoporosis
03/14/1996WO1996007417A1 Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone
03/14/1996CA2199252A1 Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone
03/14/1996CA2199251A1 Phosphonates and parathyroid hormone for osteoporosis